These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2906697)

  • 1. Systemic haemodynamic and humoral changes during urapidil treatment in hypertensive patients.
    Leonetti G; Terzoli L; Zanchetti A
    J Hypertens Suppl; 1988 Dec; 6(2):S25-9. PubMed ID: 2906697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of urapidil in the treatment of acute hypertension].
    Lehot JJ; Bonnefoy E; Dalmas JP; Filley S; Bastien O; George M
    Cah Anesthesiol; 1995; 43(1):67-76. PubMed ID: 7671060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacologic profile of urapidil. Consequences for use as an antihypertensive drug].
    van Zwieten PA
    Fortschr Med; 1992 Jun; 110(17):330-2. PubMed ID: 1353745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac morphology and function in arterial hypertension. The effects of a new multifactorial hypotensive agent: urapidil.
    Ghione S; Genovesi-Ebert A; Marabotti C; Spinazzi A; Noseda A
    Blood Press Suppl; 1994; 4():25-30. PubMed ID: 7804509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circulatory changes with urapidil (Ebrantil) in general and regional anesthesia. Studies with normo- and hypertensive patients].
    Lehmann KA; Heimig T
    Anaesthesist; 1985 Sep; 34(9):435-45. PubMed ID: 4083465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemodynamic changes and left ventricular function in patients with hypertension during an acute trial of urapidil].
    Sirakova V; Penkov N; Penev A
    Vutr Boles; 1988; 27(5):20-3. PubMed ID: 3062899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal and adrenal function following acute administration of urapidil in hypertensive patients with normal and impaired renal function].
    Wambach G; Godehardt E; Lang R; Haerlin R; Meurer KA
    Arzneimittelforschung; 1987 Aug; 37(8):960-4. PubMed ID: 3675693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of phentolamine and urapidil in controlling acute intra-operative hypertension in patients subjected to coronary artery bypass surgery.
    Hess W; Schulte-Sasse U; Tarnow J; Veit S
    Eur J Anaesthesiol; 1985 Mar; 2(1):21-7. PubMed ID: 3874774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of urapidil.
    Prichard BN; Renondin JC; Tomlinson B
    J Hypertens Suppl; 1988 Dec; 6(2):S13-9. PubMed ID: 2906695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects of urapidil in arterial hypertension and congestive heart failure.
    Messerli FH
    Drugs; 1988; 35 Suppl 6():70-3. PubMed ID: 3042361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urapidil in normotensive and spontaneously hypertensive rats: the effects on systemic and regional haemodynamics and cardiac mass.
    Kobrin I; Gallo AJ; Pegram BL; Frohlich ED
    J Hypertens; 1984 Jun; 2(3):317-20. PubMed ID: 6530543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of hypertensive crises in the perioperative period. Efficacy and safety of the use of urapidil].
    Mastronardi P; Santagata T; Noseda A; Mazzarella B
    Minerva Chir; 1996 Apr; 51(4):227-33. PubMed ID: 8927272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between peripheral hemodynamic changes and left ventricular diastolic function in hypertensive patients treated with urapidil.
    Arosio E; Pancera P; Sheiban I; Priante F; Ribul M; De Marchi S; Tonni S; Lechi A
    J Hum Hypertens; 1996 Mar; 10(3):171-6. PubMed ID: 8733035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of the hypertensive crisis with urapidil. Various effects on patients with or without coronary disease].
    Zähringer J; Klepzig M; Greif J; Ludwig B; Strauer B
    Fortschr Med; 1984 Jun; 102(22):624-8. PubMed ID: 6469170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urapidil, a dual-acting antihypertensive agent: Current usage considerations.
    Buch J
    Adv Ther; 2010 Jul; 27(7):426-43. PubMed ID: 20652659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A
    Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac and circulatory response to the intravenous administration of urapidil during general anaesthesia.
    Fontana F; Allaria B; Brunetti B; Arienta R; Favaro M; Trivellato A; Rusconi MG
    Drugs Exp Clin Res; 1990; 16(6):315-8. PubMed ID: 2086167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of studies with urapidil in elderly hypertensives.
    Hansson L; Petitet A
    Blood Press Suppl; 1995; 3():21-5. PubMed ID: 8535538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of slow release urapidil (ebrantil) in hypertensive patients with non-insulin dependent diabetes mellitus (NIDDM).
    Oren S; Turkot S; Paran E; Flandra O; Slezak L; Hof B
    J Hum Hypertens; 1996 Feb; 10(2):123-7. PubMed ID: 8867567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.